|
Description |
Symptoms |
Fatality Rate |
Treatment |

(Inhalational) Anthrax
Bacillus anthracis |
Inhaled spores germinate and release
toxins,
causing swelling in chest cavity. Possible blood and brain
infection. |
Fever, fatigue, and malaise,
starting within
two to 46 days; progresses to chest pain, cough, rapid
deterioration of health. |
Kills more than 85 percent of those
it infects,
often within one to three days after symptoms appear. |
Antibiotics (preferably
ciprofloxacin) should
be given before symptoms appear. Vaccine available, though not to
civilians. |

Smallpox
Variola Virus |
Very contagious, airborne
disease. |
About 12 to 14 days after infection.
Fever,
aches, vomiting, rash of small red spots that grow into larger,
painful pustules covering the body. |
Fatal in 30 percent of unvaccinated
patients. |
No treatment. U.S. has vaccine for
about 6
million people. Only a fraction of those vaccinated before 1972
still protected. |

(Pneumonic) Plague
Yersinia Pestis |
Natural, flea-borne form causes
bubonic plague.
Gravest threat is posed by aerosol, leading to pneumonic
plague. |
High fever, headache, and bloody
cough;
progresses to labored breathing, bluish-grayish skin color,
respiratory failure and death. |
If untreated, a person with
pneumonic plague
will almost always die within one to two days after symptoms
begin. |
Various antibiotics including
streptomycin and
gentamicin. Isolate patients. |

Viral Hemorrhagic Fever |
Highly infectious RNA viruses
including Ebola,
Marburg, Lassa, and dengue fever. Spread by rodents, ticks,
mosquitoes. |
Vary from one type of HFV to the
next. include
fever, muscle aches, exhaustion, internal bleeding. |
Varies. Death rate from dengue is as
low as 1
percent. Ebola fatality rates have reached 90
percent. |
Mainly supportive therapy.
Anti-viral drug
ribavirin useful in treating some viruses but not others (Ebola,
Marburg). |

(Inhalational) Botulism
Clostridium botulinum) |
Produces toxin that blocks nerve
signals,
inhibits muscle movement. Weapon would most likely aerosolize
toxin. |
Difficulty swallowing food, mental
numbness,
muscle paralysis, possible breathing failure. |
Inhalational form: Difficult to say
since only
a handful of cases have been recorded. |
Patients with respiratory paralysis
should be
placed on ventilator. Antitoxin given early may prevent
progression. |